Genesis Announces Private Placement of $120,000

• Most Recent Event (May 13, 2026): Genesis AI Corp. amended a previously announced private placement. The offering price was reduced from $0.06 to $0.05 per unit. Total net proceeds remain at $120,000. Up to 2.4 million units will be issued (common share + warrant). Warrants exercise price lowered to $0.07 with a 36-month expiry.
• Previous Event (April 9, 2026): Genesis announced an initial private placement of up to 2 million units at $0.06 per unit for $120,000 proceeds. Warrants were priced at $0.10 exercise price with a 24-month expiry.
• Historical Event (January 9, 2026): The company settled $200,000 of debt by issuing approximately 1.88 million shares (creditors + former board members) at a deemed price of $0.135 per share. This was classified as a related-party transaction under MI 61-101.
• Transcript Discrepancy: The provided transcript details financial results for American International Group (AIG), an insurance conglomerate with billions in premiums and underwriting income. This data is completely unrelated to Genesis AI Corp., which is raising capital in the hundreds of thousands range.

• Capital Dilution: The company has raised a total of $320,000 (financing + debt settlement) over 5 months. While immaterial for large caps, this represents a significant portion of cash flow for a micro-cap entity, indicating severe liquidity constraints.
• Price Concession: The amendment from the April offering ($0.06) to the May offering ($0.05) signals weak investor demand or management desperation to close the deal at any cost. This is a negative signal regarding market confidence in the company's valuation.
• Warrant Terms: The new warrants have a lower exercise price ($0.07 vs $0.10) and longer expiry (36 months vs 24 months). While this makes them more attractive to buyers, it increases long-term dilution risk at a lower threshold than previously offered.
• Debt Settlement: The January debt settlement involved issuing shares to former board members as part of the same transaction. This related-party nature raises governance concerns regarding capital allocation and potential conflicts of interest.
• Transcript Irrelevance: The provided transcript cannot be used to validate management promises or financial health for Genesis AI Corp. It describes a fundamentally different company (Insurance vs. Tech/Shell). Relying on this data would be a critical analytical error.

• Company Name: Genesis AI Corp.
• Flagship Project: Not explicitly detailed in news releases beyond "new business opportunities" and "general administrative expenses." The company appears to be a development-stage entity or shell given the lack of revenue disclosure in financing documents.
• Development Status: No specific product milestones, patents, or commercial contracts are mentioned in the provided news. The focus is entirely on survival capital raising.
• Transcript Mismatch Warning: The transcript provided describes AIG Insurance (General Insurance NPW up 18%, Underwriting income $774M). This data cannot be applied to Genesis AI Corp.